The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Treanda
Bendamustine Hydrochloride · BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Cephalon, LLC
NDC 63459-0391-20 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$2.96per billing unit (1 MG)HCPCS J9033 · Jul 1, 2026
- Part D plans paid (avg)$2,207.79per dosage unitgross, before rebates — matched by drug name · 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$2,971.80
Reported to Texas DSHS · 2026 annual filing · Anesta LLC A Division of Cephalon Inc
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$2.960
HCPCS J9033 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$94,280
36 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $7,321.14 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA022249
- TE code
- AP
- Approval date
- Mar 20, 2008
- Patents / exclusivity
- 44 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8436190*PED | Apr 26, 2031 |
| patent | 8436190*PED | Apr 26, 2031 |
| patent | 8436190 | Oct 26, 2030 |
| patent | 8436190 | Oct 26, 2030 |
| patent | 8344006*PED | Mar 23, 2030 |
| patent | 8344006*PED | Mar 23, 2030 |
| patent | 8669279*PED | Sep 26, 2029 |
| patent | 9533955*PED | Sep 26, 2029 |
| patent | 8445524*PED | Sep 26, 2029 |
| patent | 8445524*PED | Sep 26, 2029 |
| patent | 8669279*PED | Sep 26, 2029 |
| patent | 9533955*PED | Sep 26, 2029 |
Shortage history
- Planned discontinuation — Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Jul 23, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Bendamustine Hydrochloride (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Accord Healthcare, Inc. | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Accord Healthcare, Inc. | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Treanda — NDC 63459-0391-20," retrieved September 3, 2026, https://drugdashboards.com/drug/63459039120.
Free to cite with attribution — see how the data is put together.